Clinical Study of the Efficiency and Safety of Afala in Patients with Benign Prostatic Hyperplasia
Bulletin of Experimental Biology and Medicine(2009)
摘要
The use of afala in patients with benign prostatic hyperplasia and moderate urination disturbances reduced the symptoms of the disease, improved urodynamic parameters, and increased quality of life. Clinical efficiency of afala was comparable with the efficiency of Serenoa repens extract (reference preparation).
更多查看译文
关键词
benign prostatic hyperplasia,prostate-specific antigen,ultralow doses
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要